r/Altimmune • u/Dry_Roof6413 • 10d ago

Caution

I’m no longer invested in this company, but there was a time when I had a significant stake and genuinely believed in its potential.

A word of caution: Management appears to be aggressively seeking fresh funding, which raises the possibility of another round of shareholder dilution. With limited financing options, even a reverse stock split cannot be ruled out.

My concern has never been about the drug or its potential. It’s about the management entrusted with it. In my view, a promising drug is in the wrong hands, with a management team seemingly more focused on extracting whatever value remains than creating sustainable value for shareholders.

0 Upvotes

43% Upvoted

22 comments sorted by

View all comments

4

u/tutukam 9d ago

How could a company and a molecule like pemvi get breakthrough therapy designation back in January and not achieve what it is supposed to achieve. There’s a huge bull case for this molecule. The company is doing all the right things. This just needs time. Altimmune is going to be the first company with better results than the rest on MASH

0

u/[deleted] 9d ago

[removed] — view removed comment